Biotec Pharmacon at Anglonordic Biotech Conference

CEO Svein Lien is presenting today at the Anglonordic Biotech Conference VIII in
London. Please find further information about the conference
atwww.anglonordicbiotech.com.

Mr. Lien's presentation is available at www.biotec.no.

About Biotec Pharmacon:

Biotec Pharmacon is a Norwegian biopharmaceutical company that develops and
manufactures new immunomodulatory products and cold adapted marine enzymes. The
wholly owned Biotec BetaGlucans AS focuses on new and effective solutions within
wound care, cancer therapies and other immune related disease areas, while
ArcticZymes AS (96% owned) aspires to become a leading supplier of novel enzymes
for diagnostics and genetic research.
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)


[HUG#1512778]